Contributor Page
Singh & Associates
 
Email  |  Website  |  Articles
Contact Details
Tel: +91 11 46667000
Fax: +91 11 46667001
E-337, East of Kailash
New Delhi
110065
India
Awards
Contributor Most Read
Contributor Most Read
By Singh & Associates
On January 11, 2018, the US-FDA announced that it is requiring safety labeling changes to limit the use of prescription opioid cough and cold medicines containing codeine or hydrocodone in children younger than 18 years of age ...
By Singh & Associates
The United States Food and Drug Administration (USFDA) on January 18, 2018, released a draft guidance "Public Warning and Notification of Recalls Under 21 CFR Part 7, Subpart C" explaining new policy steps for ...
By Singh & Associates
On January 03, 2018, Novartis announced that KisqaliR (Ribociclib) has received FDA Breakthrough Therapy designation for initial endocrine-based treatment, in combination with tamoxifen or an aromatase inhibitor,...
By Singh & Associates
On January 12, 2018, the European Medicines Agency's Pharmacovigilance Risk Assessment Committee recommended the suspension of the marketing authorizations for hydroxyethyl-starch solutions for infusion across the European Union.
By Singh & Associates
On January 23, 2018, the European Medicines Agency (EMA) has published its annual report titled ‘Human medicines: Highlights of 201741.
By Singh & Associates
On January 16, 2018, the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) issued update to pharmaceutical companies on its exit preparations from the European Union (EU).
By Rajdutt Singh
Bitcoin is a digital currency that allows people to buy goods and services and exchange money without involving banks, credit card issuers or other third parties.
By Prannoy Raikhy
The Hon'ble Supreme Court in the case of "Authorized Officer, State Bank of Travancore and Ors. Vs. Mathew K.C.", MANU/SC/0054/2018, whereby, the Appellant / Bank assailed an interim order dated 24.04.2015 ...
By Singh & Associates
Haemophilia A is an inherited bleeding disorder caused by lack of a clotting protein called factor VIII and mainly affects males.
By Singh & Associates
On January 15, 2018, the World Health Organization's (WHO) Global Tuberculosis Programme has released a Position Statement on the use of delamanid in treatment of multidrug-resistant tuberculosis (MDR-TB).
By Singh & Associates
On January 29, 2018 World Health Organization (WHO) released the surveillance data of new "Global Antimicrobial Surveillance System (GLASS)" on antibiotic resistance.
By Singh & Associates
The National Pharmaceutical Pricing Authority, is an executive body under the Drugs (Prices Control) Order, 2013 under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Government of India.
By Singh & Associates
The United States Food and Drug Administration (USFDA) approved more Abbreviated New Drug Application (ANDA) in 2017 than any other year, according to its latest FY 2017 activities report.
By Singh & Associates
On January 19, 2018, the CDSCO has published clarification regarding issuance of NOC for issuing Form 29 License used to manufacture drugs for the purposes of examination, test or analysis of biological products (Vaccines 86 r-DNA products).
By Surbhi Darad
Termination of contract is considered to be lawful when a legitimate reason exists to end the contract before performance has been completed.
Contributor's Topics
More...